Coalition for Epidemic Preparedness Innovations 2024 SR
The report outlines CEPI's progress in 2024 toward its mission of accelerating vaccine development for epidemic and pandemic threats. Key highlights include the launch of the first-ever Phase 2 clinical trial for a Lassa fever vaccine and the rapid 10-day deployment of an investigational Marburg vaccine during an outbreak in Rwanda. The organization expanded its global networks, including the Vaccine Manufacturing Facility Network and the Preclinical Model Network, to enhance regional production and R&D capabilities. CEPI also integrated artificial intelligence into its Vaccine Library to improve antigen design and predict viral mutations. Furthermore, the report details strategic partnerships with organizations like Africa CDC and Gavi to strengthen the global pandemic preparedness framework.
Company: Coalition for Epidemic Preparedness Innovations
Sector: Personal & other services
Country: Norway
Year: 2024
Type: SR
Pages: 86
Back to company
Coalition for Epidemic Preparedness Innovations
Annual Progress Report
The report outlines CEPI's progress in 2024 toward its mission of accelerating vaccine development for epidemic and pandemic threats. Key highlights include the launch of the first-ever Phase 2 clinical trial for a Lassa fever vaccine and the rapid 10-day deployment of an investigational Marburg vaccine during an outbreak in Rwanda. The organization expanded its global networks, including the Vaccine Manufacturing Facility Network and the Preclinical Model Network, to enhance regional production and R&D capabilities. CEPI also integrated artificial intelligence into its Vaccine Library to improve antigen design and predict viral mutations. Furthermore, the report details strategic partnerships with organizations like Africa CDC and Gavi to strengthen the global pandemic preparedness framework.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees